Intelligent

Vialto Partners Completes Recapitalization Transaction

Transaction Completely and Definitively Transforms Vialto\'s Capital Structure,Delivering a $225 Million New Money Equity Capital Investment in Vialto and a Reduction of Approximately $550 Million of

02-26 Vialto Partners

Axiad Applauded by Frost & Sullivan for Providing Phishing-resistant Authentication with PKI-based Authentication

Axiad\'s PKI-based authentication enables scalability and flexibility in large-scale enterprise environments,elevates user experience and streamlines user access control

02-26 Frost & Sullivan

CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China

SHANGHAI,Feb. 25,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK,"CARsgen Therapeutics"),a company focused on innovative CAR T-cell therapies for the treatment of hematolo

02-26 CARsgen Therapeutics

Keypoint Intelligence Releases New Insights on the Future of the Document Scanner Market

FAIRFIELD,N.J.,Feb. 25,2025--Keypoint Intelligence,a leading provider of digital imaging market research,has released two new reports offering critical insights for the document scanner industry: Nor

02-26 Keypoint Intelligence

MediBeacon® Transdermal GFR System receives device approval in China; Peer-reviewed articles on MediBeacon technology published

Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function.

02-26 MediBeacon

Risen Achieves 30.99% Efficiency with HJT-Perovskite Tandem Solar Cells!

NINGBO,China,Feb. 26,2025-- Breaking new ground in solar innovation! Risen\'sHJT (Heterojunction Technology),when combined with aperovskitecell in a tandem structure,has achieved an impressive30.99% e

02-26 Risen Energy Co., Ltd

FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review

MELBOURNE,Australia,Feb. 26,2025--Telix Pharmaceuticals Limited (ASX: TLX,Nasdaq: TLX,Telix,the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted

02-26 Telix Pharmaceuticals

Moloco Commerce Media and MetaRouter Partner to Drive Privacy-First Ad Personalization at Scale

MetaRouter provides customer data infrastructure to power Moloco\'s ad personalization with full customer consent and privacy protections

02-26 MetaRouter

/C O R R E C T I O N -- Mindsprint/

In the news release,Mindsprint Expands Global Footprint in Australia to Bring Cutting-edge IT Solutions and Services,issued 20-Feb-2025 by Mindsprint over PR Newswire,we are advised by the company th

02-25

To answer the key questions about world multipolarity

BEIJING,Feb. 22,2025-- A report from People\'s Daily: At the recently held 61st Munich Security Conference (MSC),multipolarity became the focus of discussion.

02-25